Re: Two Visions

by Ramesh Ponnuru

Yuval, as you know, Obama shares Krugman’s perspective on this point. I wrote a little bit about these two approaches to controlling costs over at the Washington Post following yesterday’s speech. One more point worth making: When a board of experts denies funding in a quasi-monopolistic system for some treatment, it isn’t just “cutting costs.” It’s reducing spending, yes, but it is doing so in a way that can impose real costs on patients — costs that shouldn’t be ignored because they aren’t in the federal budget.